<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02886377</url>
  </required_header>
  <id_info>
    <org_study_id>2014meky049</org_study_id>
    <nct_id>NCT02886377</nct_id>
  </id_info>
  <brief_title>The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset</brief_title>
  <official_title>The Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiujuan Zhao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongshan Ophthalmic Center, Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the optical coherence tomography (OCT), visual field (VF), Visual evoked
      po-tential(VEP) characteristics between neuromyelitis optica- related optic neuritis
      (NMOSD-ON) and multiple sclerosis- related ON (MS-ON) in a Chinese cohort.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients were sub-divided into an AQP4 seropositive group and an AQP4 seronegative group,
      according to the results of the AQP4-Ab test. All patients with complete medical histories
      underwent routine neurological examinations, brain MRIs, and ophthalmological examinations,
      including best corrected visual acuity (BCVA), intraocular pressure, slit lamp and fundus
      examination, VF and VEP, laboratory testing, including blood routine, HIV HBV HCV Syphilis,
      mitochondrial DNA sequencing, and a profile of autoantibodies, including antinuclear antibody
      (ANA), extractable nuclear antigen antibodies (SSA/SSB), rheumatoid factor (RF),
      anticardiolipin antibodies (ACA), and antithyroglobulin antibody.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>retinal nerve fiber layer thickness</measure>
    <time_frame>2013.11-2016.12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual field</measure>
    <time_frame>2013.11-2016.12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual evoked potential</measure>
    <time_frame>2013.11-2016.12</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Optic Neuritis</condition>
  <arm_group>
    <arm_group_label>NMOSD-ON</arm_group_label>
    <description>NMOSD-ON included patients who met the established diagnostic criteria for NMO or NMOSD published by Wingerchuk et al,with AQP4 seropositive according to the results of the AQP4-Ab test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MS-ON</arm_group_label>
    <description>MS-ON group patients included typical acute demyelinating ON with brain lesions fulfilling the revised McDonald criteria or clinical isolate syndrome (CIS), with AQP4 seronegative according to the results of the AQP4-Ab test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Age- and gender- matched healthy controls.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood test of anti-AQP4 antibody</intervention_name>
    <description>Patients were sub-divided into an AQP4 seropositive group and an AQP4 seronegative group, according to blood test of the AQP4-Ab.</description>
    <arm_group_label>NMOSD-ON</arm_group_label>
    <arm_group_label>MS-ON</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        250
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Optic neuritis patients

        Exclusion Criteria:

          -  The presence of significant refractive errors (3D of spherical equivalent refraction
             or 2D of astigmatism), intraocular pressure of 21 mmHg or higher, systemic conditions
             that could affect the visual system, and a history of ocular trauma or concomitant
             ocular diseases, including a history of media opacification, ocular pathologies
             affecting the cornea, lens, retinal disease, glaucoma, or laser therapy. All patients
             in the study groups had an episode of ON more than six months before the study
             inclusion time point.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hui Yang</last_name>
    <role>Study Director</role>
    <affiliation>World Health Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jian Zhang</last_name>
    <phone>020-87334687</phone>
    <email>zoccrc@mail.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hui Yang, PHD</last_name>
      <phone>+8613710584767</phone>
    </contact>
    <contact_backup>
      <phone>+8613710584767</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2016</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xiujuan Zhao</investigator_full_name>
    <investigator_title>doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuritis</mesh_term>
    <mesh_term>Optic Neuritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

